On Monday, Corcept Therapeutics Inc (NASDAQ: CORT) was -3.42% drop from the session before settling in for the closing price of $82.65. A 52-week range for CORT has been $49.00 – $117.33.
A company in the Healthcare sector has jumped its sales by 9.89% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -18.59%. With a float of $93.21 million, this company’s outstanding shares have now reached $105.12 million.
Corcept Therapeutics Inc (CORT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Corcept Therapeutics Inc stocks. The insider ownership of Corcept Therapeutics Inc is 11.39%, while institutional ownership is 74.70%. The most recent insider transaction that took place on Dec 02 ’25, was worth 1,601,526. In this transaction Chief Development Officer of this company sold 20,000 shares at a rate of $80.08, taking the stock ownership to the 1,235 shares. Before that another transaction happened on Dec 01 ’25, when Company’s insider sold 20,000 for $79.52, making the entire transaction worth $1,590,490. This insider now owns 7,904 shares in total.
Corcept Therapeutics Inc (CORT) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.26 earnings per share (EPS) during the time that was less than consensus figure (set at 0.42) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.23% during the next five years compared to 9.89% growth over the previous five years of trading.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
You can see what Corcept Therapeutics Inc (CORT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.33. Likewise, its price to free cash flow for the trailing twelve months is 51.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.88, a number that is poised to hit 0.38 in the next quarter and is forecasted to reach 1.22 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.78 million. That was inferior than the volume of 1.16 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 37.66%.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 53.42%, which indicates a significant increase from 16.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.37 in the past 14 days, which was higher than the 3.03 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $78.66, while its 200-day Moving Average is $73.97. However, in the short run, Corcept Therapeutics Inc’s stock first resistance to watch stands at $81.98. Second resistance stands at $84.13. The third major resistance level sits at $85.29. If the price goes on to break the first support level at $78.67, it is likely to go to the next support level at $77.51. The third support level lies at $75.36 if the price breaches the second support level.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
There are 105,188K outstanding shares of the company, which has a market capitalization of 8.40 billion. As of now, sales total 675,040 K while income totals 141,210 K. Its latest quarter income was 207,640 K while its last quarter net income were 19,670 K.
